With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.
From a small biology research center established in 1968 in a three-room apartment in Nice to the world’s 7th largest laboratory, a look back at the beginnings of great human adventure.
Nurture entrepreneurship, stimulate innovation, demonstrate our engagement, foster a customer-driven approach, pay attention to people and choose sustainability...
Allerderm Created by Roger Brandt
In 1982, Texas businessman Roger Brandt created Allerderm, a leader in the animal skin care company.
Virbac Corporation Established
Drawing attention from France, Virbac Group created Virbac Inc., later known as Virbac Corporation, to enter the US market by acquiring Allerderm.
Virbac Corporation Merges with Agri-Nutrition Group & Settles in Fort Worth
After impressive sales in the 1990s, Virbac Corporation decided to merge with Agri-Nutrition Group, a well-known St. Louis-based manufacturer of dental hygiene, nutritional and grooming products for cats and dogs. When the merger was complete, Virbac Corporation settled on Fort Worth, Texas as a permanent home.
C.E.T.® Brand of Products Created
Established in 2001 through the Agri-Nutrition merger, Virbac created the C.E.T. Brand of Products for dental health. Today, the brand includes toothbrushes, toothpaste, hygiene chews, hygiene kits, diagnostic tests and tartar control chews. In 2016, Virbac began selling the C.E.T.® OraStrip® Dental Diagnostic Test, the first of its kind in the market to detect active periodontal disease.
Virbac Corporation Acquires Animal Health Products from King Pharmaceuticals
The acquisition added SOLOXINE® Tablets, PANCREZYME® Tablets and Powder, TUMIL-K® Gel, Tablets and Powder, UROEZE® Tablets and Powder, and AMMONIL® Tablets to Virbac Corporation’s portfolio.
Dr. Erik R. Martinez Appointed as President and Chief Executive Officer
Martinez was with the Virbac Group since 1994, where he began as General Manager of Mexico, then Regional Director for Latin America and finally, Area Director SANZA (South Africa, New Zealand, Australia) where he was responsible for overseeing all operations.
IVERHART MAX® (Ivermectin/pyrantel pamoate/prazlquantel) Chewable Tablets Introduced
Virbac introduces IVERHART MAX® to the market, which is the first broad-spectrum chewable anthelmintic in the United States for use in dogs to prevent canine heartworm disease and for the treatment and control of roundworms, hookworms and tapeworms.
IVERHART MAX® (ivermectin/pyrantel pamoate/praziquantel) Chewable Tablets - For use in dogs only. All dogs should be tested for heartworm infection before starting a preventive program. Use with caution in sick, debilitated, or underweight animals and dogs weighing less than 10 lbs. The safe use of this drug has not been evaluated in pregnant or lactating bitches. Adverse reactions following the use of ivermectin include: Depression/lethargy, vomiting, anorexia, diarrhea, mydriasis, ataxia, staggering, convulsions and hypersalivation. For complete product information refer to the product insert. To obtain a package insert, contact Veterinary Technical Product Support at 1-800-338-3659.
Launched ANXITANE® (L-theanine) Chewable Tablets for Dogs and Cats
Virbac releases ANXITANE® Chewable Tablets to help reduce anxiety-related issues in dogs and cats.
Virbac Canada, Inc. Established
Virbac establishes Virbac Canada, Inc. to expand its business into Canada. Virbac US and Virbac Canada constitute Virbac's North America Area operations, one of Virbac Group’s global areas.
C.E.T.® Home Dental Care Celebrates 25 Years of Dental Excellence
Virbac Corporation announces the 25th anniversary of C.E.T.® Home Dental Care. With 25 years of leadership in veterinary home dental care, C.E.T. Brand Products are the most tenured and respected veterinary brands in the market today.
Paul R. Hays Named President & CEO, Virbac Corporation and Area Director, North America
In his new role, Hays oversees all corporate functions for Virbac North America and is responsible for the growth and profitability of both the U.S. and Canadian operations. He has extensive experience in animal health.
Virbac announces the successful closing, on January 2nd, of its agreement with Eli Lilly and Company to acquire two major parasiticides for dogs in the United States: SENTINEL® FLAVOR TABS® and SENTINEL® SPECTRUM®, previously marketed by Novartis Animal Health.
SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron) - Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information refer to the product insert. To obtain a package insert, contact Veterinary Technical Product Support at 1-800-338-3659. SENTINEL® SPECTRUM® (milbemycin oxime/lufenuron/praziquantel) - Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information refer to the product insert. To obtain a package insert, contact Veterinary Technical Product Support at 1-800-338-3659.
Virbac US Expands in Bridgeton, Mo.
The company grew its presence in the U.S. and Canada with a $37.9 million expansion to its manufacturing and R&D facility in Bridgeton, creating 144 new jobs.
Launch of MOVOFLEX™ Soft Chews
The soft chews are the latest advancement in canine joint health supplementation, providing comprehensive canine joint support in a once-a-day palatable soft chew.
2017 marks Virbac’s 30th year of business in the U.S. Virbac Group has grown to become one of the largest independent veterinary pharmaceutical companies in the world and has successfully produced and launched hundreds of products.
Virbac Corporation Selects Kansas City for New North American Distribution Center
The company announces it will consolidate its North American product warehousing and distribution in the KC Animal Health Corridor, located in an approximately 150,000-sq.-ft. facility in Hunt Midwest SubTropolis in Kansas City, Missouri. Hunt Midwest SubTropolis was chosen due to its central location, transportation access, and unique underground environment.